Author Archives: WSJ.com: Health

Goal Is More Flu Shots for Americans

Health officials are gearing up to persuade more Americans to get vaccinated against the flu this fall, in the aftermath of last year’s swine-flu pandemic. (Source: WSJ.com: Health)

Goal Is More Flu Shots, Sooner

Health officials are gearing up to persuade more Americans to get vaccinated against the flu this fall, in the aftermath of last year’s swine-flu pandemic. They’re also using lessons learned last year to speed the production and development of vaccine. (Source: WSJ.com: Health)

J&J Contact Lenses Recalled

A J&J unit voluntarily recalled about 100,000 boxes of daily disposable contact lenses in certain Asian and European markets because of a manufacturing issue linked to complaints of stinging or pain. (Source: WSJ.com: Health)

What Can Play Tricks on Your Memory

Jeremy Singer-Vine summarizes new medical findings on false memory; muscle growth; walking speed and cognitive impairment; tai chi and fibromyalgia; autism; back pain. (Source: WSJ.com: Health)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

J&J Unit Recalls Contact Lenses in Asia, Europe

A J&J unit voluntarily recalled about 100,000 boxes of daily disposable contact lenses in certain Asian and European markets because of a manufacturing issue linked to complaints of stinging or pain. (Source: WSJ.com: Health)

J&J Unit Recalls Contact Lenses in Asia, Europe

A J&J unit voluntarily recalled about 100,000 boxes of daily disposable contact lenses in certain Asian and European markets because of a manufacturing issue linked to complaints of stinging or pain. (Source: WSJ.com: Health)

FDA Rejects Jazz Drug as Treatment

An FDA panel rejected a proposed Jazz Pharmaceuticals drug to treat the pain disorder fibromyalgia partly on concerns that the drug could be misused and abused. (Source: WSJ.com: Health)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

FDA Panel Backs Cymbalta for Chronic Pain

An FDA advisory panel narrowly backed an effort by Lilly to expand use of its antidepressant Cymbalta as a treatment for chronic pain. (Source: WSJ.com: Health)

FDA Raises Concerns About Fibromyalgia Drug

The FDA raised safety concerns about a proposed Jazz Pharmaceuticals drug to treat the pain disorder fibromyalgia, including the potential for misuse and abuse of the product. (Source: WSJ.com: Health)

How Technology Tries Our Eyes

Many people who show up at an eye doctor complaining about things like headaches and neck pain aren’t being adequately tested for vision in the middle distance—the area most commonly used by computer users. (Source: WSJ.com: Health)